跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Cyclo(his-pro)
首页
药物
Cyclo(his-pro)
Experimental
Small Molecule
Cyclo(his-pro)
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
11
H
14
N
4
O
2
CAS 编号
53109-32-3
UNII ID
Q10817UXVT
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Template-fixed peptidomimetics
US 8399611 B2
申请人: OBRECHT DANIEL
优先权: 2007
CN
US
11 件公开
USE OF CYCLO(HIS-PRO) (CHP) FOR PREVENTING, AMELIORATING, OR TREATING FIBROSIS
US 2022202897 A1
申请人: NOVMETAPHARMA CO LTD
优先权: 2019
US
WO
5 件公开
NOVEL POLYMORPHIC FORMS OF CYCLO (-HIS-PRO)
EP 4265615 A1
申请人: NOVMETAPHARMA CO LTD
优先权: 2018
CN
EP
US
3 件公开
PEG-MODIFIED CYCLIC DIPEPTIDES
EP 4594325 A4
申请人: NOVMETAPHARMA CO LTD
优先权: 2022
EP
US
WO
3 件公开
Compositions and methods for treating alzheimer's disease and dementia
US 10058520 B2
申请人: SONG MOON K
优先权: 2008
CN
US
3 件公开
Composition for cell protection containing cyclo histidine-proline as active ingredient
US 10918693 B2
申请人: NOVMETAPHARMA CO LTD
优先权: 2016
US
3 件公开
Polymorphic forms of Cyclo (-His-Pro) and methods of use to treat kidney disease
US 11820834 B2
申请人: NOVMETAPHARMA CO LTD
优先权: 2020
US
3 件公开
USE OF CYCLO(HIS-PRO) (CHP) FOR ENHANCING EXERCISE PERFORMANCE, IMPROVING MUSCLE FUNCTION, OR PREVENTING, ALLEVIATING, OR TREATING MUSCLE DISEASES
WO 2025127437 A1
申请人: NOVMETAPHARMA CO LTD
优先权: 2023
CN
WO
2 件公开
Cyclopeptide derivatives
US 2002198142 A1
申请人: MERCK PATENT GMBH
优先权: 2002
US
Alpha-intermedin cyclic analog peptide and use thereof
CN 1709906 A
申请人: CHINESE SCIENCE TECHNOLOGY UNI
优先权: 2005
CN
第 1 / 3 页
上一页
下一页
药物
反馈